As of 1 August 2023 the National Institute of Pharmacy and Nutrition (abbreviated in Hungarian: ‘OGYÉI’) will cease to exist after more than its 60 years of existence as independent authority and will merge into the National Public Health Centre.
This latter will act as legal successor of OGYÉI under a new name of National Public Health and Pharmacy Centre (abbreviated in Hungarian: ‘NNGYK’).
In force from 1st June 2023: Following several amendments and clarifications to the Government De- cree No. 197/2022 (VI.4.) on Extra Profit Taxes (the “Decree on extraprofit taxes”) which entered into force in December 2022, in the Official Gazette no. 79/ 2023 published on 31 May 2023, the Government decided on new significant changes affecting certain subjects of the pharmaceutical in- dustry regulated by Government Decree no. 206/ 2023 ( V.31) (“Amending Decree no. 4.”) which entered into force as of 1 June 2023.
New whistle-blower act (Act XXV of 2023) has just been published in the Official Gazette (25 May 2023), that will affect all organisations with over 50 employees, as they will be required to operate a whistleblowing system.
In force from 1st March 2023: The last amendment to Government Decree No. 197/2022 (VI.4.) on Extra Profit Taxes (the "Amending Decree no. 2") which entered into force in December 2022, left many unanswered and questions open to interpretation, so everyone was eagerly awaiting for further clarification from the legislator on this issue.
More Articles …
- New due diligence obligations under the German Supply Chain Act (“LkSG”)
- Amendment to Government Decree No. 197/2022 (VI.4.) on Extra Profit Taxes affecting pharmaceutical manufacturers
- Amendments to the Labour Code effective as from 1 January 2023 from Employer’s perspective
- Have you already checked the „TT index” of your company?